Insider Selling: Phreesia, Inc. (NYSE:PHR) Insider Sells 465 Shares of Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) insider Yvonne Hui sold 465 shares of the company's stock in a transaction on Thursday, July 17th. The shares were sold at an average price of $26.89, for a total transaction of $12,503.85. Following the sale, the insider directly owned 29,816 shares in the company, valued at approximately $801,752.24. The trade was a 1.54% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Yvonne Hui also recently made the following trade(s):

• On Friday, July 18th, Yvonne Hui sold 626 shares of Phreesia stock. The stock was sold at an average price of $26.23, for a total transaction of $16,419.98.
• On Wednesday, July 16th, Yvonne Hui sold 422 shares of Phreesia stock. The shares were sold at an average price of $26.95, for a total transaction of $11,372.90.
• On Tuesday, July 15th, Yvonne Hui sold 307 shares of Phreesia stock. The shares were sold at an average price of $27.27, for a total transaction of $8,371.89.
• On Monday, July 7th, Yvonne Hui sold 571 shares of Phreesia stock. The stock was sold at an average price of $28.85, for a total value of $16,473.35.
• On Tuesday, June 10th, Yvonne Hui sold 582 shares of Phreesia stock. The shares were sold at an average price of $28.00, for a total value of $16,296.00.

Phreesia Trading Down 2.2%

Shares of NYSE:PHR traded down $0.61 during trading on Thursday, reaching $27.09. 420,413 shares of the company were exchanged, compared to its average volume of 577,443. The business's fifty day simple moving average is $26.58 and its 200-day simple moving average is $26.43. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.95 and a quick ratio of 1.95. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $30.53. The firm has a market capitalization of $1.61 billion, a PE ratio of -36.60 and a beta of 0.72.

Phreesia (NYSE:PHR - Get Free Report) last released its quarterly earnings data on Wednesday, May 28th. The company reported ($0.07) EPS for the quarter, topping the consensus estimate of ($0.13) by $0.06. Phreesia had a negative return on equity of 16.23% and a negative net margin of 9.83%. The company had revenue of $115.94 million for the quarter, compared to the consensus estimate of $115.00 million. During the same period last year, the business posted ($0.05) EPS. Phreesia's quarterly revenue was up 14.5% on a year-over-year basis. On average, research analysts anticipate that Phreesia, Inc. will post -1.1 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on PHR shares. Truist Financial boosted their target price on Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a research report on Thursday, May 29th. KeyCorp lifted their price objective on shares of Phreesia from $28.00 to $35.00 and gave the stock an "overweight" rating in a research note on Monday, July 14th. DA Davidson upgraded shares of Phreesia to a "strong-buy" rating in a research report on Tuesday. Canaccord Genuity Group dropped their price target on shares of Phreesia from $35.00 to $34.00 and set a "buy" rating for the company in a research note on Thursday, May 29th. Finally, Wall Street Zen raised shares of Phreesia from a "hold" rating to a "buy" rating in a research report on Sunday, June 1st. Eleven investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Phreesia presently has a consensus rating of "Buy" and a consensus target price of $32.27.

Institutional Trading of Phreesia

Institutional investors and hedge funds have recently made changes to their positions in the company. Invesco Ltd. grew its holdings in Phreesia by 0.9% during the 4th quarter. Invesco Ltd. now owns 40,249 shares of the company's stock worth $1,013,000 after acquiring an additional 357 shares in the last quarter. Diversified Trust Co lifted its position in shares of Phreesia by 1.0% in the 2nd quarter. Diversified Trust Co now owns 45,042 shares of the company's stock worth $1,282,000 after purchasing an additional 426 shares during the period. NewEdge Advisors LLC boosted its stake in shares of Phreesia by 12.1% during the fourth quarter. NewEdge Advisors LLC now owns 4,256 shares of the company's stock valued at $107,000 after purchasing an additional 459 shares in the last quarter. Arcadia Investment Management Corp MI boosted its stake in shares of Phreesia by 0.7% during the first quarter. Arcadia Investment Management Corp MI now owns 92,770 shares of the company's stock valued at $2,371,000 after purchasing an additional 615 shares in the last quarter. Finally, QRG Capital Management Inc. increased its holdings in Phreesia by 8.0% during the first quarter. QRG Capital Management Inc. now owns 11,118 shares of the company's stock valued at $284,000 after buying an additional 827 shares during the period. 92.10% of the stock is currently owned by institutional investors.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.